Applied Spectral Imaging (ASI) | a ZYTOMICS company

Medical Equipment ManufacturingCalifornia, United States51-200 Employees

Applied Spectral Imaging (ASI) is a global leader in biomedical imaging solutions for Pathology, Cytogenetics, and Life Sciences.
Since 1993, ASI has delivered cutting-edge imaging platforms that streamline the diagnostic workflow - from image acquisition to quantitative analysis, reporting, and LIS integration. With more than 5,000 systems installed in over 80 countries, ASI’s technology drives diagnostic accuracy and laboratory efficiency through advanced applications in karyotyping, FISH, digtal pathology, IHC, and spectral imaging.

Now part of ZYTOMICS, a leader in cancer diagnostics, ASI integrates its pioneering imaging capabilities with ZYTOMICS’ strengths in automation and reagents. Together, they offer laboratories a comprehensive end-to-end solution that unites reagents, automation, and digital imaging. Probe-agnostic and scanner-agnostic, ASI’s platform provides the flexibility labs need to apply their preferred protocols with confidence.

ASI’s portfolio includes FDA-cleared products such as BandView, FISHView, SpotScan for CEP XY, UroVysion, ALK, and HER2/neu FISH, as well as the HiPath IHC Family for HER2, ER, PR, and Ki67. All products are IVDR compliant.
Backed by a global distribution network and a reputation for outstanding support, ASI continues to set the standard in diagnostic imaging - committed to improving patient care with reliable, flexible, and future-ready solutions.
Together, ZYTOMICS and ASI combine a broad reagent portfolio with advanced digital imaging - because Every Diagnosis Counts.

Privacy Policy - https://spectral-imaging.com/privacy-policy/

Sign up for free to view info

Email Format Employee directory